News Focus
News Focus
icon url

tredenwater2

08/18/22 9:14 PM

#370982 RE: Steady_T #370972

I suppose that Anavex could sit on the AD NDA while the Rett submission is in the works but I think that would create a lot of backlash from investors.



Unless you switch out a lagging CRO for the Ph 3 AD trial data scrub. :)
icon url

Kb1123

08/18/22 11:10 PM

#370989 RE: Steady_T #370972

If Anavex halts the rate of decline for 25% of the patients is that enough to meet their primary endpoints ?
icon url

Investor2014

08/19/22 1:37 AM

#370996 RE: Steady_T #370972

Your post reads almost as something I might have written :-)
icon url

jimmy_mcyoloswag

08/19/22 5:13 AM

#371001 RE: Steady_T #370972

"I suppose that Anavex could sit on the AD NDA while the Rett submission is in the works but I think that would create a lot of backlash from investors."

Which would be very much a "Missling thing" to do.. :D